0121-0807 0121-0807 S0121-08072020000300261 10.18273/revsal.v52n3-2020008 Colombia 00 09 2020 00 09 2020 52 3 261 284

1 Invima 2020 2 1994 60 6 6 516-20 3 2003 74 4 4 328-38 4 2006 69 12 12 1692-6 5 2009 47 2 2 113-20 6 2017 1-199 7 2018 18 14 14 1199-219 8 International Organization for Standardization 9 Ministerio de Salud y Protección Social 2013 1-73 10 1996 345 447-65 11 2007 Segunda 1-253 12 2007 4 1-804 13 NIST 2020 14 1996 Second 1-501 15 1993 4 1-371 16 2007 1 1-202 17 2017 1 57-117 18 2011 40 4 4 043101 19 1999 842 1-2 1-2 29-49 20 1990 503 1-24 21 1999 1-655 22 2009 1-410 23 1997 1-298 24 2016 80 328-44 25 1996 1-381 26 1999 1-241 27 2019 49 3 3 325-50 28 2019 53 23 23 13583-97 29 2005 2 5 1532-4 30 2001 90 5 5 541-4 31 2005 38 4 4 790-6 32 2009 1-262 33 The United States Pharmacopeia 2018 1 1254 34 The British Pharmacopeia 1999 1 494495 35 2017 1-233 36 1999 105 3 3 141-53 37 2020 38 2019 101-2 39 40 1993 1-547 41 1987 1-308 42 1999 1-298 43 1993 Second 1-370 44 2020 1-330 45 2009 1-328 46 1987 125-8 47 Ministerio de la Protección Social 2008 53-5 48 2013 53 5 5 507-16 49 Food and Drug Administration (FDA) 1997 21 182.10 50 2018 4 2 2 1-17 51 2009 8 5 5 455-65 52 2013 7 14 14 179-87 53 2006 6 3-4 3-4 135-59 European Medicines Agency 2008 55 1991 6 189-92 56 2008 44 3 3 391-5 57 2000 1-256 58 2010 122 6 6 98-106 59 1991 32 11 11 1381-5 60 2005 330 7504 7504 1366 61 2005 331 7528 7528 1310-6 62 2004 63 7 7 759-66 63 1991 31 7 7 588-98 64 1995 22 3 3 820-7 65 2007 75 2-3 2-3 148-55 66 2015 26 4 4 285-91 67 2014 2 4 4 414-20 68 2019 100 5 5 1058-65 69 WHO 2017 70 OECD/EUIPO 2019 71 World Bank 2016 72 2017 73 Decreto 1156 de 2018 2018 1-25